• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: Cardiovascular Disease

Contactless atrial fibrillation detection system achieves clinical-grade accuracy

AI, atrial fibrillation, 20 May 2025/in Cardiology, Cardiovascular Disease, E-News /by panglobal

A groundbreaking contactless detection system for atrial fibrillation using radio technology and artificial intelligence has demonstrated clinical-grade diagnostic accuracy. Published in Nature Communications, the innovative system records heart mechanical motion via radar sensing and analyses it using neural networks, enabling detection without physical contact and potentially facilitating early diagnosis before symptoms appear.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/05/Afib_Diagram.jpg 1326 2300 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-05-20 18:00:472025-05-19 09:05:36Contactless atrial fibrillation detection system achieves clinical-grade accuracy

New study reveals TCAR outperforms TF-CAS for stroke prevention in carotid artery stenosis

carotid artery stenting, 28 April 2025/in Cardiovascular Disease, E-News, Surgery /by panglobal

Surgical transcarotid artery revascularisation (TCAR) demonstrated significantly lower stroke risk compared to percutaneous transfemoral carotid artery stenting (TF-CAS) over a 3-year follow-up period, according to a comprehensive comparative effectiveness study published in JAMA Network Open, offering critical guidance for physicians and patients selecting carotid stenting procedures.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/carotid-2.jpg 936 869 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-28 13:29:012025-04-28 13:29:01New study reveals TCAR outperforms TF-CAS for stroke prevention in carotid artery stenosis
Elixir Medical has launched its LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Europe

Elixir Medical launches new intravascular lithotripsy system in Europe

, 18 April 2025/in Cardiovascular Disease, Product News /by panglobal

Elixir Medical’s LithiX Hertz Contact IVL system receives CE Mark approval for treating calcified coronary lesions without external energy source.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/04/Elixir-Medical-LithiX-Device.jpg 394 700 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-04-18 08:00:462025-05-21 14:39:56Elixir Medical launches new intravascular lithotripsy system in Europe
quit smoking

ESC Congress 2024: Quitting smoking halves cardiovascular risk in coronary artery disease patients

cardiovascular disease, ESC, Research, smoking, 2 September 2024/in Cardiology, Cardiovascular Disease, E-News /by panglobal

New research reveals that patients with stable coronary artery disease who quit smoking at any point after diagnosis can reduce their risk of major cardiovascular events by nearly 50%. The study, presented at ESC Congress 2024, also found that merely reducing smoking habits had minimal impact on cardiovascular risk.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/smoking.jpg 584 876 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-02 10:53:292024-09-02 10:53:29ESC Congress 2024: Quitting smoking halves cardiovascular risk in coronary artery disease patients
Professor Maciej Banach of the Medical University of Lodz

ESC Congress 2024: Experts call for routine screening of Lipoprotein(a) in cardiovascular health

cardiovascular disease, ESC, Europe, lipoprotein(a), screening, 2 September 2024/in Cardiology, Cardiovascular Disease, E-News /by panglobal

A series of groundbreaking studies from Poland have shed new light on the prevalence and impact of lipoprotein(a) [Lp(a)] on cardiovascular health, prompting calls for routine measurement of this important biomarker.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/Maciej_Banach.jpg 1274 1000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-02 10:48:022024-09-02 10:48:02ESC Congress 2024: Experts call for routine screening of Lipoprotein(a) in cardiovascular health

New blood platelet score unveils hidden cardiovascular risk

blood platelets, cardiovascular risk, stroke, tool, 20 August 2024/in Cardiovascular Disease, E-News /by panglobal

A novel genetic scoring system developed by researchers at NYU Grossman School of Medicine could revolutionise the detection of platelet hyperreactivity, offering a more precise method to identify patients at risk of heart attacks and strokes.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/08/blood_platelets.jpg 720 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-08-20 10:50:302024-08-20 10:50:30New blood platelet score unveils hidden cardiovascular risk
statins

New cardiovascular risk equations could dramatically reduce statin and antihypertensive prescribing

cardiovascular disease, JAMA, PREVENT study, risk prediction, statins, 29 July 2024/in Cardiovascular Disease, E-News /by panglobal

A study published in JAMA estimates that adopting new cardiovascular disease risk prediction equations could make nearly 16 million fewer US adults eligible for preventive medications, potentially leading to over 100,000 additional occurrences of myocardial infarction or stroke over 10 years.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/07/statins.jpg 1068 1600 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-07-29 17:05:012024-07-25 14:29:55New cardiovascular risk equations could dramatically reduce statin and antihypertensive prescribing

Latest issue of International Hospital

April 2024

29 May 2025

ADHD genetics pioneer maps molecular pathways to behaviour

28 May 2025

Breakthrough in vivo gene therapy targets newborn blood stem cells

28 May 2025

Major study exposes social media’s toxic impact on child mental health

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription